Cargando…
NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications
Despite major progress in mantle cell lymphoma (MCL) therapeutics, MCL remains a deadly disease with a median survival not exceeding four years. No single driver genetic lesion has been described to solely give rise to MCL. The hallmark translocation t(11;14)(q13;q32) requires additional genetic alt...
Autores principales: | Deshotels, Leigh, Safa, Firas M., Saba, Nakhle S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299455/ https://www.ncbi.nlm.nih.gov/pubmed/37373427 http://dx.doi.org/10.3390/ijms241210280 |
Ejemplares similares
-
Establishment and characterization of a new mantle cell lymphoma cell line with a NOTCH2 mutation, Arbo
por: Safa, Firas, et al.
Publicado: (2022) -
Testicular involvement in mantle cell lymphoma: An analysis of 16 patients.
por: Alkhalili, Samer, et al.
Publicado: (2023) -
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
por: Lakhotia, Rahul, et al.
Publicado: (2022) -
Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma
por: Klener, Pavel
Publicado: (2019) -
The B cell receptor signaling pathway in mantle cell lymphoma
por: Merolle, Maria I., et al.
Publicado: (2018)